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Edited by Ulf-Ingo Flu¨ggeAbstract Panax ginseng produces triterpene saponins called
ginsenosides, which are classiﬁed into two groups by the skeleton
of aglycones, namely dammarane type and oleanane type. Dam-
marane-type ginsenosides dominate over oleanane type not only
in amount but also in structural varieties. However, their sapoge-
nin structure is restricted to two aglycones, protopanaxadiol and
protopanaxatriol. So far, the genes encoding oxidosqualene cy-
clase (OSC) responsible for formation of dammarane skeleton
have not been cloned, although OSC yielding oleanane skeleton
(b-amyrin synthase) has been successfully cloned from this plant.
In this study, cDNA cloning of OSC producing dammmarane
triterpene was attempted from hairy root cultures of P. ginseng
by homology based PCR method. A new OSC gene (named as
PNA) obtained was expressed in a lanosterol synthase deﬁcient
(erg7) Saccharomyces cerevisiae strain GIL77. LC-MS and
NMR analyses identiﬁed the accumulated product in the yeast
transformant to be dammarenediol-II, demonstrating PNA to
encode dammarenediol-II synthase.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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ginseng1. Introduction
Panax ginseng is one of the most famous oriental medicinal
plants used as crude drugs in Asian countries for more than
5000 years. The major pharmacologically active constituents
of ginseng are triterpene saponins called ginsenosides [1]. Until
now, more than 30 ginsenosides (hereafter abbreviated as
G-Xmn), such as G-Rb1, -Rg1, -Ro, etc., have been isolated [2]
and studied for their biological activities. Slight diﬀerence of
structure causes drastic change of pharmacological activity.
For example, G-Rg1 shows central nervous stimulating activ-
ity, while G-Rb1 suppressing activity. Recently, G-Rg3, G-
Rh1 and G-Rh2 were reported to show anti-cancer activity
and considered to be promising anti-cancer drugs [3,4]. In spite
of these prospects, diﬃculty of their supply in pure form in
quantity has prevented them from development for clinical
medicines. Cultivation of P. ginseng takes long time, generallyAbbreviations: OSC, oxidosqualene cyclase; G-Xmn, ginsenoside
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doi:10.1016/j.febslet.2006.08.044more than 4–5 years, and needs many labors and extra eﬀorts
such as protection from direct sunlight. Isolation and puriﬁca-
tion of each ginsenoside also needs a lot of tasks. Chemical
synthesis is not practical in terms of both quantity and cost.
Various biological systems, including a large-scale bioreac-
tor system (1–10 tons) of adventitious root cultures [5,6], for
production of ginsenosides have been developed and solved
some problems associated with cultivation in the ﬁeld. How-
ever, ginsenoside productivity did not exceed that of the origi-
nal plant. Genetic engineering of biosynthesis might be one of
the choices to improve productivity. Overexpression of the bio-
synthetic genes in ginseng plant would improve ginsenoside
contents. Alternatively, expression of the genes for biosyn-
thetic enzymes in heterologous host organisms, hopefully in
fast growing microbes such as yeast or Escherichia coli, would
lead to ginsenoside production in quantities. The latter ap-
proach would also solve the problems associated with isola-
tion, as the target compounds are produced with negligible
background metabolites. Genetic engineering discussed above
seems to be the most promising way to obtain ginsenosides
in large quantities and for that purpose thorough understand-
ing of ginsenoside biosynthesis and cloning of the relevant
genes are highly expected.
Ginsenosides are classiﬁed into two groups by the structure of
aglycones, dammarane type and oleanane type. Major ginseno-
sides are dammarane type, including G-Rb1 and G-Rg1 whose
genuine aglycones are protopanaxadiol and protopanaxatriol,
respectively. Oleanane type is represented by only one minor
saponin, G-Ro, whose aglycone is oleanolic acid. Ginsenosides
are biosynthesized from oxidosqualene by a sequence of three
steps, namely cyclization, hydroxylation and glycosidation
(Fig. 1). Cyclization of oxidosqualene is a biosynthetic branch-
ing point not only for phytosterols and triterpenes, but also for
dammarane and oleanane type ginsenosides. In our previous
study, three OSC (oxidosqualene cyclase) activities yielding
cycloartenol, b-amyrin and dammarenediol-II were detected in
microsomal fraction prepared from P. ginseng hairy root cul-
tures [7]. cDNAs of cycloartenol synthase and b-amyrin syn-
thase were successfully cloned by homology based PCR from
the same source [8,9] and also from other plant species [10–
13]. However, dammarenediol-II synthase cDNA has not been
obtained from any plants including P. ginseng.
To design and materialize biological systems for eﬃcient gin-
senoside production by recombinant technology as an ultimate
goal, cDNA cloning of dammarenediol-II synthase, the ﬁrst
committed enzyme for the biosynthesis of genuine sapogenin
of dammarane type ginsenosides, has been attempted in this
study.blished by Elsevier B.V. All rights reserved.
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Fig. 1. Proposed biosynthesis of ginsenosides in P. ginseng.
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2.1. Panax ginseng hairy root culture
The hairy root culture of P. ginseng was generated by infecting Agro-
bacterium rhizogenes [14]. The culture was maintained, in a MS liquid
medium containing 3% sucrose, on a rotary shaker at 50 rpm and
25 C in the dark and subcultured every 4 weeks.
2.2. PCR and sequence analysis
Synthesis of oligo DNAs was done by Nihon Bioservice (Saitama,
Japan). PCR was performed by Robo Cycler Gradient 40 (Strata-
gene). Sequencing was carried out by DNA Sequencer Long Read
IR 4200 (LI-COR).
2.3. cDNA cloning
RNA was extracted by phenol-SDS method from the 28 day old
hairy root culture by the same method as previously reported [8].
RNA was reverse transcribed to produce cDNAs using reverse
transcriptase (Superscript II, Invitrogen) and oligo dT primer,
RACE32 (50-GACTCGAGTCGACATCGATTTTTTTTTTTTTT-30)
with dNTP (0.2 mM) in a volume of 20 ll following the manufacturer’s
protocol. The resulting cDNA mixture was used as the template in the
following PCR.
PCRs were performed with a set of primer, 463S (5 0-
MGICAYATHWSIAARGGIGCITGG-3 0) and 711A (5 0-CKRTAY-
TCICCIARIGCCCADATIGGRAA-3 0) (1 lg of primers were used
in all PCR procedures for cloning), using Ex Taq. DNA polymerase
(Takara Biochemical) with dNTP (0.2 mM) in a ﬁnal volume of
100 ll following the manufacturer’s protocol. PCR was carried out
for 30 cycles with a program (94 C, 1 min, 42 C, 2 min, 75 C,
3 min, and ﬁnal extension at 75 C, 10 min). The PCR product
(860 bp) was subcloned to the plasmid vector (pT7-Blue, Novagen).
Seventeen colonies were picked up in total, and nucleotide sequence
was determined. A new gene (2 clones, named as PNA) was cloned
together with known genes (PNX, PNY and PNZ).
Based on the sequence of PNA, speciﬁc primers were designed to ob-
tain the 3 0 and 5 0 end sequences. RACE PCRs were carried out follow-
ing the method described in our previous paper with somemodiﬁcations [8]. Used primers were as follows. For 3 0-RACE;
PNA627S (5 0-ACCCTATCWGGGTTTGCTTCT-3 0), PNA648S (5 0-
GGTGTTAAATTTTTCCTTTCAACA-30). For 5 0-RACE; PNA-
633A (5 0-AGAAGCAAACCCWGATAGGGT-3 0), PNA365A
(5 0-CTCGGTGGCACCATAGCGCATTAG-3 0), PNA356A (5 0-AA-
CAACTCTTTTTAGACCTCTTTT-3 0) and PNA340A (5 0-TTTGAG-
GAATGGTTCACTAAAGTA-3 0).
To obtain the full-length clones, nested PCR was carried out. The
ﬁrst PCR was carried out with PNA-50N-32 (5 0-GACACC-
ACATACCAACAAGAA-3) and PNA-30C + 36 (5 0-TGGAATT-
TAGCGCATTAATTCATC-3 0) primers. The second PCR was carried
out with KpnI-PNA-N (5 0-GAAGAGGTACCATGTGGAAGCA-
GAAGGGTGCC-3 0 KpnI site in bold face) and XhoI-PNA-C (5 0-
AAGAACTCGAGTTAAATTTTGAGCTGCTGGTG-3 0 XhoI site
in bold face) primers. PCR was carried out with the same condition
described above, except that the annealing temperature was 52 C.
The 2.3-kb PCR product was digested with KpnI and XhoI and
ligated into the corresponding sites of pYES2 (Invitrogen) to con-
struct the plasmid pYES2-PNA. The obtained full length cDNA
clone, PNA was sequenced in both strands. This sequence is available
under Accession No. AB265170 in DDBJ sequence-database and
also available in Japanese patent applications (Jan. Kokai Tokkyo
Koho) under application number 2002-223787 (applied date: July 31,
2002).2.4. Expression in Saccharomyces cerevisiae
The plasmid pYES2-PNA was transferred to S. cerevisiae strain
GIL77 [8] using Frozen-EZ Yeast Transformation II kit (ZYMO
RESEARCH). The transformant was inoculated in 20 ml synthetic
complete medium without uracil (SC-U), containing ergosterol
(20 lg/ml), hemin chloride (13 lg/ml) and Tween 80 (5 mg/ml), and
incubated at 37 C for 2 days. Media were changed to SC-U with
the same supplements and 2% galactose in place of glucose. Cells were
collected and resuspended in the same volume of 0.1 M potassium
phosphate buﬀer (pH 7.0) supplemented with 2% glucose and hemin
chloride (13 lg/ml) and further incubated for 24 h at 30 C. Cells were
collected and reﬂuxed with 2 ml of 20% KOH/50% EtOH aq. for
5 min. After extraction with the same volume of hexane, the extract
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Fig. 2. TLC analysis of PNA product. Hexane extracts from trans-
formed cells by void vector (lane 1) and by the vector harboring PNA
(lane 2) were applied onto a silica gel TLC plate, which was developed
twice with benzene–acetone (19:1) and visualized with phosphomo-
lybdic acid.
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Fig. 3. HPLC proﬁle of PNA product. After separated by TLC, PNA prod
202 nm. Proﬁle of authentic dammarenediol-II was shown in (B).
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was developed twice with benzene:acetone = 19:1 and visualized with
phosphomolybdic acid (Fig. 2).
2.5. Products determination by LC-MS and NMR
The band migrating just below ergosterol was scraped oﬀ the plate
and extracted with acetone. The extract was concentrated and applied
to LC-MS (LCQ, Thermo Quest) equipped with a HPLC (Agilent,
1100 series) and an ODS-80Tm column (4.6 · 250 mm, Tosoh) main-
tained at 40 C, eluted with 90% CH3CN at 1.0 ml/min, and monitored
by UV 202 nm absorbance (Fig. 3). Under this condition, (20S)-epimer
(dammarenediol-II) can be separated from (20R)-epimer (dammarene-
diol-I) with baseline resolution (Rts for 20S; 15 min and for 20R;
16 min) [7].
In APCIMS analysis, the authentic dammarenediol-II gave no
molecular ion peak, but the ion peaks at m/z 427 and 409 which come
from [M+H]+ by elimination of one and two water molecule(s), respec-
tively (data not shown). MS/MS spectra with m/z 427 as the parent ion
showed a dominant peak at m/z 409, dehydration fragment peak, with-
out other signiﬁcant peaks (data not shown). MS/MS spectra with m/z
409 as the parent ion showed a complex fragmentation pattern which is
identical to that of the PNA product as shown in Fig. 4.
2.6. NMR analysis of the PNA products accumulated in GIL77
transformants
For preparative scale culture of the transformant with pYES2-PNA,
6-L culture was prepared. Induction and resting cultures were per-
formed as described above. After reﬂuxing with 100 ml of 20%
KOH/50% EtOH aq. for 1 h, the mixture was extracted with 100 ml
of hexane for three times, combined and concentrated. The extract
was puriﬁed by silica gel column chromatography with benzene–ace-
tone as an eluent. The fractions showing a slightly polar spot than that
of ergosterol on TLC were collected (1 mg).5.05
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Fig. 4. LC-MS analysis of PNA product. MS/MS spectra from the peak of m/z = 409 as a parent ion were shown in (A) (PNA product) and (B)
(authentic dammarenediol-II).
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TMS as an internal standard.
1H NMR (500 MHz, CDCl3): d 0.77 (3H, s), 0.84 (3H, s), 0.87 (3H,
s), 0.96 (3H, s), 0.97 (3H, s), 1.14 (3H, s), 1.62 (3H, s), 1.70 (3H, s), 3.20
(1H, dd, J = 5.0, 10.5 Hz), 5.12 (1H, t, J = 7.0 Hz).
13C NMR (125 MHz, CDCl3): d 15.33, 15.47, 16.20, 16.43, 17.70,
18.25, 21.51, 22.53, 24.79 (C-21), 25.38, 25.74, 27.38, 27.52, 27.98,
31.16, 35.20, 37.10, 38.96, 39.01, 40.34, 40.45 (C-22), 42.26, 49.82,
50.28, 50.60, 55.82, 75.42, 78.96, 124.61, 131.61.
All spectra were identical to those reported for dammarenediol-II
[15,16]. C-21 and C-22 of dammarenediol-II (underlined) resonate at
distinct chemical shifts from those, 23.5 (C-21) and 41.8 (C-22) ppm,
of dammarenediol-I [16].3. Results and discussion
3.1. RNA and cDNA preparation
As time course study of ginsenoside production in hairy root
cultures showed that dammarane type ginsenosides start to
accumulate on day 17 and reach their maximum on day 27
after inoculation to a new medium (unpublished result), we ex-
pected the presence of ample transcripts of dammarenediol-II
synthase gene on day 21. Therefore, in our previous study,
RNA was prepared from cultures on day 21. Although cyclo-
artenol synthase (PNX) [8], b-amyrin synthase (PNY [8] and
P. Tansakul et al. / FEBS Letters 580 (2006) 5143–5149 5147PNY2 [9]) and lanosterol synthase (PNZ) [17] genes were
cloned from this RNA preparation by PCRs, dammarene-
diol-II synthase cDNA was not obtained. One of the possible
reasons for this might be that the transcription of dammarene-
diol-II synthase gene has already started on day 21 but has not
exceeded those of other OSCs in quantity. In this study, there-
fore, we waited one more week for RNA preparation, from
day 21 to day 28, to clone dammarenediol-II synthase.
3.2. Ampliﬁcation of DNA fragment using degenerate primers
PCRs with four combinations (162S-623A, 162S-711A,
463S-923A and 463S-711A) of degenerate primers designed
from the conserved sequences of the known oxidosqualene cyc-
lases [8] were carried out. PCR products were subcloned to
plasmid vector, and sequenced. Among the PCR products
ampliﬁed with 463S and 711A primers, one new sequence
(860 bp in length and named PNA) was found, which shows
65% identities to PNY (b-amyrin synthase of P. ginseng) in
amino acid level.
3.3. Sequence of PNA
Sequence of full length PNA was obtained by RACE meth-
od [18]. It contained an ORF of 2310 nucleotides encoding a
polypeptide of 770 amino acids with a predicted molecular
mass of 88.3 kDa. Among the known triterpene synthases, P.
ginseng b-amyrin synthase (PNY) shows the highest identity
value (57%) to PNA. However, high identity of 82% between
two b-amyrin synthase isozymes, PNY and PNY2, of P. gin-
seng suggested the enzyme function of PNA to be diﬀerent
from b-amyrin synthase.
3.4. Expression of PNA in Saccharomyces cerevisiae
The DNA fragment of ORF was ampliﬁed by PCR with
primers based on the obtained sequence and ligated into the
multi-cloning site of yeast expression vector pYES2 (Invitro-
gen) under the control of GAL1 promoter to yield pYES2-
PNA. Lanosterol synthase deﬁcient S. cerevisiae strain
GIL77 [8] was transformed with pYES2-PNA.
The transformant was cultured for 2 days. After induction of
GAL1 promoter by addition of galactose, cells were further
incubated in 0.1 M potassium phosphate for 1 day. Then, cells
were collected, lysed and extracted with hexane. The hexane
extract was analyzed by silica gel TLC. As shown in Fig. 2,
a new spot with the same Rf value with that of authentic
dammarenediol-II appeared just below ergosterol.
3.5. Product identiﬁcation by LC-MS and NMR
The band corresponding to the PNA product was scraped
oﬀ the plate, extracted with acetone, and analyzed by LC-HO
HO
HO
lupanediol
Fig. 5. Triterpene-diols directly produMS. A peak at 15.05 min, the same retention time with authen-
tic dammarenediol-II (Fig. 3), showed the same MS fragmen-
tation pattern (Fig. 4), indicating the accumulated product to
be dammarenediol-II.
In order to obtain rigorous proof of structure, the product
(1 mg) was prepared by silica gel column chromatography
from 6 L culture, and subjected to 1H and 13C NMR analyses.
The results clearly proved that the product is dammarenediol-
II, and thus PNA to encode a dammarenediol-II synthase.
Both stereoisomers, 20S and 20R, of dammarenediol have
been reported as natural products. Most ginsenosides have S
conﬁguration at C-20. Our previous study demonstrated that
dammarenediol produced by microsomal fraction prepared
from P. ginseng hairy root cultures is a 20S isomer and no
trace of 20R isomer was detected [7]. However, this result
was obtained with crude microsomal proteins and there left
some ambiguity as regard the presence of dammarenediol-II
synthase in this plant. Successful cloning of dammarenediol-
II synthase cDNA in this study provided a rigorous proof
for the presence of dammarenediol-II synthase in P. ginseng.
As mentioned above, PNA yielded dammarenediol-II, (20S)-
isomer, as a sole product, demonstrating that water addition to
dammarenyl cation is stereospeciﬁc. It is important to note
that quenching of carbocation by water addition, which termi-
nates cyclization reaction, is precisely controlled by the en-
zyme. So far, three OSCs including PNA have been cloned
which terminate the reaction by water addition. LUP1 from
Arabidopsis thaliana, a low ﬁdelity lupeol synthase, produces
lupanediol (Fig. 5) in addition to lupeol in nearly equal
amount [19]. Although its product speciﬁcity is leaky, water
addition to lupenyl cation to produce lupanediol is stereospe-
ciﬁc as demonstrated by feeding of [1,2-13C2]acetate to LUP1
yeast transformant [20]. Recently, another triterpene synthase
from A. thaliana was identiﬁed to produce arabidiol, a tricyclic
triterpene-diol [21]. Arabidiol (Fig. 5) is a single diastereomer
of (3S,13R)-malabarica-17,21-dien-3,14-diol, although its con-
ﬁguration at C-14 has not been determined. It is noteworthy
that these three triterpene-diol synthases strictly control the
direction of water addition to produce only one diastereomer.
In other words, in the active site of these enzymes, the position
of water that terminates the reaction, is rather restricted. Un-
ique mechanism of these clones to terminate the cyclization by
water addition without hydride and methyl shifts and skeletal
rearrangements might suggest a common evolutional path for
these enzymes. However, these three OSCs did not form a
branch but are dispersed in a phylogenetic tree constructed
with the known OSCs (data not shown). Further structural
studies would disclose the intricate mechanism displayed by
these enzymes.arabidiol
OH
14
ced by oxidosqualene cyclases.
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Dammarenediol-II synthase cDNA (PNA) was successfully
cloned from P. ginseng hairy root cultures on day 28. RT–
PCR with RNA prepared from those on day 21 with the spe-
ciﬁc primers ampliﬁed the PNA fragment, but its quantity was
quite low (data not shown). Although a precise time course
expression study is lacking, not enough accumulation of
PNA transcript on day 21 might be the reason why we failed
to clone PNA using the degenerate primers in our previous
study.
Recently, EST clone with identical sequence to PNA was iso-
lated from ﬂower bud (GenBank, AB122080) and annotated as
b-amyrin synthase. Now that its function is established in this
study, it should be corrected to dammarenediol-II synthase.
The presence of dammarenediol-II synthase gene in ﬂower
buds well accounts for the isolation of dammarane type ginse-
nosides from this part of the plant [22–24].
In a recent report, four EST clones isolated from the library
prepared from in vitro cultured seedlings are annotated as
OSC. High content of ginsenosides in this cultures suggests
the presence of PNA among them, although their sequences
were not indicated in the paper [25].
Genome sequence analysis revealed the presence of 13 OSC
genes in A. thaliana. Our extensive cDNA cloning of OSCs
from Taraxacum oﬃcinale uncovered the presence of at least
10 OSC genes in this plant (unpublished result). From P. gin-
seng, ﬁve OSCs including PNX, PNY, PNY2, PNZ and PNA
have been cloned [8,9,17]. These indicate the presence of multi-
ple copies of OSC in one plant species to be general and we are
still continuing cDNA cloning of OSCs from ginseng expecting
the presence of some more genes.
Successful cloning of dammarenediol-II synthase cDNA in
this study has provided a signiﬁcant step for production of
dammarane type ginsenosides by heterologous expression sys-
tems, since subsequent hydroxylation(s) and glycosidation(s)
lead to a varieties of ginsenoside structures. Recently, a cyto-
chrome P450 (CYP93E1) from Glycine max has been identiﬁed
to hydroxylate C-24 position of b-amyrin and sophoradiol.
Co-expression of this hydroxylase with b-amyrin synthase in
S. cerevisiae resulted in production of olean-12-ene-3b,24-diol
(24-hydroxy-b-amyrin), an intermediate leading to soyasapo-
nins of legumes [26]. In a similar manner, protopanaxadiol
and protopanaxatriol, the aglycones of ginsenosides, could
be produced by yeast expression system if the genes of relevant
(C-12 and C-6) hydroxylases become available.
In addition to production of ginsenoside aglycones by
heterologous expression, dammarenediol-II synthase cDNA
could be utilized for high production of ginsenosides in gin-
seng plant itself. The aglycones of dammarane type ginseno-
sides, protopanaxadiol and protopanaxatriol, are rarely
detected in ginseng roots and hairy root cultures, suggesting
the higher expression of hydroxylases and sugar-transferases
than dammarenediol-II synthase, and thus dammarenediol-
II formation could be considered as a rate-limiting step in
ginsenoside biosynthesis. This implies that introduction and
overexpression of dammarenediol-II synthase cDNA in gin-
seng plant could directly lead to higher production of ginse-
nosides. Therefore, availability of dammarenediol-II synthase
cDNA alone could make it possible to engineer ginsenoside
biosynthesis to improve P. ginseng quality, since ginseng with
high dammarane type ginsenoside content is rated as high
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